Evidence map›Paper›PMID 33432383›Full record

ArticleEJNMMI physics2021

Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model.

Tatsuhiko Sato, Takuya Furuta, Yuwei Liu, Sadahiro Naka, Shushi Nagamori, Yoshikatsu Kanai, Tadashi Watabe

Open access · goldAbstract read
In one paragraph

Article in EJNMMI physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Monte Carlo microdosimetry ofEJNMMI physics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Monte Carlo-calculated perturbation correction factors in clinical proton beams using PHITS.Technical innovations & patient support in radiation oncology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pharmaceutics · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tatsuhiko SatoNuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai, Ibaraki, 319-1195, Japan. sato.tatsuhiko@jaea.go.jp.ORCID http://orcid.org/0000-0001-9902-7083
Takuya FurutaNuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai, Ibaraki, 319-1195, Japan.
Yuwei LiuDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita, Japan.
Sadahiro NakaDepartment of Radiology, Osaka University Hospital, Suita, Japan.
Shushi NagamoriDepartment of Laboratory Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Yoshikatsu KanaiDepartment of Bio-system Pharmacology, Graduate School of Medicine, Osaka University, Suita, Japan.
Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita, Japan.
The University of Osaka · JPJapan Atomic Energy Agency · JPJikei University School of Medicine · JPOsaka University Hospital · JP

Funding

Japan Science and Technology Agency JPMJOP1721
6 · The paper itself

Abstract

backgroundAn individual dosimetry system is essential for the evaluation of precise doses in nuclear medicine. The purpose of this study was to develop a system for calculating not only absorbed doses but also EQDX(α/β) from the PET-CT images of patients for targeted alpha therapy (TAT), considering the dose dependence of the relative biological effectiveness, the dose-rate effect, and the dose heterogeneity.

methodsA general-purpose Monte Carlo particle transport code PHITS was employed as the dose calculation engine in the system, while the microdosimetric kinetic model was used for converting the absorbed dose to EQDX(α/β). PHITS input files for describing the geometry and source distribution of a patient are automatically created from PET-CT images, using newly developed modules of the radiotherapy package based on PHITS (RT-PHITS). We examined the performance of the system by calculating several organ doses using the PET-CT images of four healthy volunteers after injecting

resultsThe deposition energy map obtained from our system seems to be a blurred image of the corresponding PET data because annihilation γ-rays deposit their energies rather far from the source location. The calculated organ doses agree with the corresponding data obtained from OLINDA 2.0 within 20%, indicating the reliability of our developed system. Test calculations by replacing the labeled radionuclide from

conclusionsAs an extension of RT-PHITS, an individual dosimetry system for nuclear medicine was developed based on PHITS coupled with the microdosimetric kinetic model. It enables us to predict the therapeutic and side effects of TAT based on the clinical data largely available from conventional external radiotherapy.

Indexed as

EQDXIndividual dosimetryMicrodosimetryMonte CarloTargeted alpha therapy

Identifiers

PMID33432383
PMCPMC7801536
OpenAlexW3121021118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.